ADARx Pharmaceuticals周四表示,其扩大规模的美国首次公开募股已募集4.463亿美元,反映出投资者对生物科技上市的兴趣日益增长。
ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings.
点「原文对照」整页切到原文,或双击某段只看那段的原文。
ADARx Pharmaceuticals周四表示,其扩大规模的美国首次公开募股已募集4.463亿美元,反映出投资者对生物科技上市的兴趣日益增长。
ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings.